Vanguard Group’s IDEAYA Biosciences IDYA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$174M Buy
5,019,324
+97,116
+2% +$3.1M ﹤0.01% 1619
2025
Q3
$134M Sell
4,922,208
-19,737
-0.4% -$477K ﹤0.01% 1729
2025
Q2
$104M Sell
4,941,945
-150,674
-3% -$2.89M ﹤0.01% 1817
2025
Q1
$83.4M Buy
5,092,619
+14,535
+0.3% +$310K ﹤0.01% 1870
2024
Q4
$131M Buy
5,078,084
+282,936
+6% +$8.01M ﹤0.01% 1743
2024
Q3
$152M Buy
4,795,148
+528,375
+12% +$20M ﹤0.01% 1684
2024
Q2
$150M Buy
4,266,773
+111,016
+3% +$4.4M ﹤0.01% 1656
2024
Q1
$182M Buy
4,155,757
+679,985
+20% +$29.2M ﹤0.01% 1583
2023
Q4
$124M Buy
3,475,772
+504,275
+17% +$15.1M ﹤0.01% 1748
2023
Q3
$80.2M Buy
2,971,497
+141,844
+5% +$3.6M ﹤0.01% 1920
2023
Q2
$66.5M Buy
2,829,653
+508,655
+22% +$10.5M ﹤0.01% 2060
2023
Q1
$31.9M Buy
2,320,998
+31,196
+1% +$520K ﹤0.01% 2390
2022
Q4
$41.6M Buy
2,289,802
+365,202
+19% +$6.14M ﹤0.01% 2272
2022
Q3
$28.7M Buy
1,924,600
+171,759
+10% +$2.23M ﹤0.01% 2465
2022
Q2
$24.2M Buy
1,752,841
+176,584
+11% +$1.96M ﹤0.01% 2549
2022
Q1
$17.6M Buy
1,576,257
+62,134
+4% +$916K ﹤0.01% 2841
2021
Q4
$35.8M Buy
1,514,123
+98,175
+7% +$2.28M ﹤0.01% 2534
2021
Q3
$36.1M Buy
1,415,948
+345,014
+32% +$8.06M ﹤0.01% 2540
2021
Q2
$22.5M Buy
1,070,934
+192,252
+22% +$3.95M ﹤0.01% 2779
2021
Q1
$20.6M Buy
878,682
+161,055
+22% +$3.11M ﹤0.01% 2767
2020
Q4
$10M Buy
717,627
+24,309
+4% +$329K ﹤0.01% 2991
2020
Q3
$8.71M Buy
693,318
+192,926
+39% +$2.39M ﹤0.01% 2856
2020
Q2
$7.11M Buy
500,392
+411,874
+465% +$3.24M ﹤0.01% 2921
2020
Q1
$365K Buy
88,518
+10,851
+14% +$76.8K ﹤0.01% 3735
2019
Q4
$582K Sell
77,667
-1,053
-1% -$7.51K ﹤0.01% 3767
2019
Q3
$708K Buy
78,720
+43,720
+125% +$334K ﹤0.01% 3736
2019
Q2
$349K Buy
+35,000
New +$381K ﹤0.01% 3887

Other funds holding IDYA